[go: up one dir, main page]

PE20070007A1 - Metodos para sintetizar derivados de 6-alquilaminoquinolina - Google Patents

Metodos para sintetizar derivados de 6-alquilaminoquinolina

Info

Publication number
PE20070007A1
PE20070007A1 PE2006000538A PE2006000538A PE20070007A1 PE 20070007 A1 PE20070007 A1 PE 20070007A1 PE 2006000538 A PE2006000538 A PE 2006000538A PE 2006000538 A PE2006000538 A PE 2006000538A PE 20070007 A1 PE20070007 A1 PE 20070007A1
Authority
PE
Peru
Prior art keywords
alkyl
alkylaminoquinoline
synthesizing
derivatives
methods
Prior art date
Application number
PE2006000538A
Other languages
English (en)
Inventor
Warren Chew
Youchu Wang
Carolyn Discafany-Marro
Allan Wissner
John Patrick Mcginnis Iii
Sridhar Krishna Rabidran
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070007A1 publication Critical patent/PE20070007A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO DE PREPARACION QUE CONSISTE: A) ACOPLAR UNA ANILINOQUINONA DE FORMULA III CON UN ACIDO DE FORMULA VII PARA OBTENER II; B) DESPROTEGER II PARA OBTENER UN COMPUESTO DE FORMULA I; DONDE X ES CICLOALQUILO C3-C7 SUSTITUIDO O NO, ARILO BICICLICO O HETEROARILO DE 8-12 ATOMOS QUE CONTIENE 1-4 HETEROATOMOS SELECCIONADOS DE N, S, O, ENTRE OTROS; V ES ETILENO, ACETILENO; PG ES UN GRUPO PROTECTOR DE AMINOS; R4 ES ALQUILO C1-C6; Z ES NH, N-(ALQUILO C1-C6); R1, G2 Y R3 SON CADA UNO H, HALOGENO, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; n ES 0-1; x ES 0-3; y ES 0-1; z ES 0-3. UN COMPUESTO OBTENIDO MEDIANTE DICHO PROCEDIMIENTO ES: (E) N-{4-[3-CLORO-4-(2-PIRIDINILMETOXI)ANILINO]3-CIANO-7-ETOXI-6-QUINOLINIL}-4-(METILAMINO)-2-BUTENAMIDA, SIENDO UTIL EN EL TRATAMIENTO DE CANCER
PE2006000538A 2005-05-25 2006-05-22 Metodos para sintetizar derivados de 6-alquilaminoquinolina PE20070007A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68504005P 2005-05-25 2005-05-25

Publications (1)

Publication Number Publication Date
PE20070007A1 true PE20070007A1 (es) 2007-02-12

Family

ID=36794434

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000538A PE20070007A1 (es) 2005-05-25 2006-05-22 Metodos para sintetizar derivados de 6-alquilaminoquinolina

Country Status (20)

Country Link
US (1) US20060270670A1 (es)
EP (1) EP1883630A2 (es)
JP (1) JP2008542266A (es)
KR (1) KR20080016604A (es)
CN (1) CN101180273A (es)
AR (1) AR054192A1 (es)
AU (1) AU2006249596A1 (es)
BR (1) BRPI0610142A2 (es)
CA (1) CA2608589A1 (es)
CR (1) CR9545A (es)
GT (1) GT200600215A (es)
IL (1) IL187301A0 (es)
MX (1) MX2007014774A (es)
NO (1) NO20075726L (es)
PA (1) PA8676301A1 (es)
PE (1) PE20070007A1 (es)
RU (1) RU2007140957A (es)
TW (1) TW200716556A (es)
WO (1) WO2006127203A2 (es)
ZA (1) ZA200710143B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008942A2 (en) * 2005-07-11 2007-01-18 Aerie Pharmaceuticals, Inc. Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
EP1910297B1 (en) * 2005-07-11 2016-05-25 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
JP5235887B2 (ja) 2006-09-20 2013-07-10 アエリー ファーマシューティカルズ インコーポレイテッド Ｒｈｏキナーゼ阻害剤
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
US8394826B2 (en) 2009-05-01 2013-03-12 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
JP5622842B2 (ja) * 2009-05-14 2014-11-12 コーロン ライフ サイエンス インク アルキルアミン誘導体の製造方法
JP5791725B2 (ja) 2010-09-29 2015-10-07 インターベット インターナショナル ベー． フェー． Ｎ−ヘテロアリール化合物
EP2621923B1 (en) 2010-09-29 2017-03-29 Intervet International B.V. N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
CN102649778A (zh) * 2011-02-23 2012-08-29 苏州波锐生物医药科技有限公司 喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
CN104203242B (zh) * 2012-04-04 2017-03-15 杭州德润玉成生物科技有限公司 取代的喹啉类作为布鲁顿酪氨酸激酶抑制剂
EP4335507A3 (en) 2013-03-15 2024-06-05 Aerie Pharmaceuticals, Inc. Combination therapy
US9556191B2 (en) 2013-04-28 2017-01-31 Sunshine Lake Pharma Co., Ltd. Aminoquinazoline derivatives and their salts and methods of use thereof
JP6832946B2 (ja) 2015-11-17 2021-02-24 アエリエ ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤およびその中間体の調製方法
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
HUE057402T2 (hu) * 2016-04-28 2022-05-28 Jiangsu Hengrui Medicine Co Tirozinkináz inhibitor és azok származékainak elõállítási módszere
BR112019003945A2 (pt) 2016-08-31 2019-05-21 Aerie Pharmaceuticals, Inc. composições oftálmicas
MX2019011784A (es) 2017-03-31 2019-11-18 Aerie Pharmaceuticals Inc Compuestos de aril ciclopropil-amino-isoquinolinil amida.
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
KR102713340B1 (ko) * 2022-11-08 2024-10-02 경희대학교 산학협력단 고리화첨가 반응과 고리축소 반응의 연속 반응을 이용한 피롤로[1,2-a]퀴놀린의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
US6288082B1 (en) * 1998-09-29 2001-09-11 American Cyanamid Company Substituted 3-cyanoquinolines
IL151249A0 (en) * 2000-03-13 2003-04-10 American Cyanamid Co Use of cyanoquinolines for treating or inhibiting colonic polyps
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
DE60332915D1 (de) * 2002-02-05 2010-07-22 Wyeth Llc Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
CL2004000016A1 (es) * 2003-01-21 2005-04-15 Wyeth Corp Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
CA2535385A1 (en) * 2003-08-19 2005-03-03 Wyeth Holdings Corporation Process for the preparation of 4-amino-3-quinolinecarbonitriles
CN1930128A (zh) * 2004-01-16 2007-03-14 惠氏公司 受体酪氨酸激酶抑制剂的喹啉中间体及其合成

Also Published As

Publication number Publication date
WO2006127203A3 (en) 2007-05-03
GT200600215A (es) 2006-12-26
BRPI0610142A2 (pt) 2011-01-04
KR20080016604A (ko) 2008-02-21
WO2006127203A2 (en) 2006-11-30
NO20075726L (no) 2008-02-04
AR054192A1 (es) 2007-06-06
JP2008542266A (ja) 2008-11-27
US20060270670A1 (en) 2006-11-30
RU2007140957A (ru) 2009-06-27
CR9545A (es) 2008-01-10
IL187301A0 (en) 2008-04-13
MX2007014774A (es) 2008-02-19
AU2006249596A1 (en) 2006-11-30
CA2608589A1 (en) 2006-11-30
ZA200710143B (en) 2008-11-26
TW200716556A (en) 2007-05-01
PA8676301A1 (es) 2009-03-31
EP1883630A2 (en) 2008-02-06
CN101180273A (zh) 2008-05-14

Similar Documents

Publication Publication Date Title
PE20070007A1 (es) Metodos para sintetizar derivados de 6-alquilaminoquinolina
CY1124357T1 (el) Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
PE20130647A1 (es) Indoles
PE20080401A1 (es) DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
ATE433447T1 (de) Pyrimiidinverbindungen
AR067896A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
AR035548A1 (es) Compuestos organicos
NO20050429L (no) Substituert kinolin-CCR5-reseptorantagonister
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
AR035111A1 (es) Procedimiento para preparar un compuesto de pirimidinona
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
ATE264268T1 (de) Verfahren zur herstellung von zsm-5 und zsm-11
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
AR041786A1 (es) Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
ATE453621T1 (de) Substituierte 4-phenylpiperidinamide als tachykininantagonisten und serotoninwiederaufnahmehemmer
CO5640113A2 (es) Amidas de acido pieprazinil o piepridinilamin-sulfamico como inhibidores de la sulfatasa esteroidal
AR057451A1 (es) Metodos para preparar derivados de acido glutamico
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung

Legal Events

Date Code Title Description
FX Voluntary withdrawal